Genentech, Inc.
1,624
110
211
1,059
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
17.5%
285 terminated/withdrawn out of 1624 trials
78.8%
-7.7% vs industry average
13%
207 trials in Phase 3/4
68%
719 of 1059 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1624)
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
Role: collaborator
Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
Role: collaborator
New Assessment System in Measuring Symptom Distress in Cancer Patients
Role: collaborator
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Role: lead
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Role: lead
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
Role: lead
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Role: collaborator
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Role: lead
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Role: collaborator
Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)
Role: lead
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
Role: collaborator
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
Role: collaborator
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
Role: collaborator
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Role: collaborator
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Role: collaborator
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
Role: collaborator
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Role: collaborator
A Dose-Escalation Study of RO7875913 in Healthy Participants
Role: lead
A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Role: lead
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
Role: lead